Literature DB >> 17942469

Bias reduction with an adjustment for participants' intent to dropout of a randomized controlled clinical trial.

Andrew C Leon1, Hakan Demirtas, Donald Hedeker.   

Abstract

BACKGROUND: Attrition, which is virtually ubiquitous in randomized controlled clinical trials, introduces problems of increased bias and reduced statistical power. Although likelihood-based statistical models such as mixed-effects models can accommodate incomplete data, the assumption of ignorable attrition is usually required for valid inferences.
PURPOSE: In an effort to make the ignorability assumption more plausible, we consider the value of one readily obtained covariate that has been recommended by others, asking participants to rate their Intent to Attend the next assessment session.
METHODS: Here we present a simulation study that compares the bias and coverage in mixed-effects outcome analyses that do and do not include Intent to Attend as a covariate.
RESULTS: For the simulation specifications that we examined, the results are promising in the sense of reduced bias and greater precision. Specifically, if the time-varying Intent to Attend variable is associated with attrition, outcome and treatment group, bias is substantially reduced by including it in the outcome analyses. LIMITATIONS: Analyses that are adjusted in this way will only yield unbiased estimates of efficacy if attrition is ignorable based on the self-rated intentions.
CONCLUSIONS: Accounting for participants' Intent to Attend the next assessment session will reduce attrition bias under conditions examined here. The item adds little burden and can be used both for data analyses and to identify participants at risk of attrition.

Entities:  

Mesh:

Year:  2007        PMID: 17942469     DOI: 10.1177/1740774507083871

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  20 in total

1.  Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorder.

Authors:  Louisa G Sylvia; Noreen A Reilly-Harrington; Andrew C Leon; Christine I Kansky; Terence A Ketter; Joseph R Calabrese; Michael E Thase; Charles L Bowden; Edward S Friedman; Michael J Ostacher; Dan V Iosifescu; Joanne Severe; Michelle Keyes; Andrew A Nierenberg
Journal:  Clin Trials       Date:  2011-11-10       Impact factor: 2.486

2.  To attend, or not to attend: Examining caregiver intentions and study compliance in a pediatric, randomized controlled trial.

Authors:  Jacqueline A Sullivan; Anna M Wiese; Kelly M Boone; Joseph Rausch; Sarah A Keim
Journal:  Clin Trials       Date:  2020-01-27       Impact factor: 2.486

3.  On the prevention and analysis of missing data in randomized clinical trials: the state of the art.

Authors:  Daniel O Scharfstein; Joseph Hogan; Amir Herman
Journal:  J Bone Joint Surg Am       Date:  2012-07-18       Impact factor: 5.284

4.  Person mobility in the design and analysis of cluster-randomized cohort prevention trials.

Authors:  Sam Vuchinich; Brian R Flay; Lawrence Aber; Leonard Bickman
Journal:  Prev Sci       Date:  2012-06

5.  The design and conduct of clinical trials to limit missing data.

Authors:  R J Little; M L Cohen; K Dickersin; S S Emerson; J T Farrar; J D Neaton; W Shih; J P Siegel; H Stern
Journal:  Stat Med       Date:  2012-07-25       Impact factor: 2.373

6.  Missing Data in Longitudinal Trials - Part B, Analytic Issues.

Authors:  Juned Siddique; C Hendricks Brown; Donald Hedeker; Naihua Duan; Robert D Gibbons; Jeanne Miranda; Philip W Lavori
Journal:  Psychiatr Ann       Date:  2008-12-01

7.  Proactive recruitment predicts participant retention to end of treatment in a secondhand smoke reduction trial with low-income maternal smokers.

Authors:  Bradley N Collins; E Paul Wileyto; Melbourne F Hovell; Uma S Nair; Karen Jaffe; Natalie M Tolley; Janet Audrain-McGovern
Journal:  Transl Behav Med       Date:  2011-09       Impact factor: 3.046

8.  Enhancing clinical trial design of interventions for posttraumatic stress disorder.

Authors:  Andrew C Leon; Lori L Davis
Journal:  J Trauma Stress       Date:  2009-12

9.  A novel application of the Intent to Attend assessment to reduce bias due to missing data in a randomized controlled clinical trial.

Authors:  Dustin J Rabideau; Andrew A Nierenberg; Louisa G Sylvia; Edward S Friedman; Charles L Bowden; Michael E Thase; Terence A Ketter; Michael J Ostacher; Noreen Reilly-Harrington; Dan V Iosifescu; Joseph R Calabrese; Andrew C Leon; David A Schoenfeld
Journal:  Clin Trials       Date:  2014-05-28       Impact factor: 2.486

10.  Identifying risk for attrition during treatment for depression.

Authors:  Diane Warden; Madhukar H Trivedi; Stephen R Wisniewski; Ira M Lesser; Jeff Mitchell; G K Balasubramani; Maurizio Fava; Kathy Shores-Wilson; Diane Stegman; A John Rush
Journal:  Psychother Psychosom       Date:  2009-09-08       Impact factor: 17.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.